As hallmarks of type 2 diabetes mellitus (T2DM), insulin resistance and visceral adiposity are both linked to thyroid hormone sensitivity. In this study, we aimed to investigate the association of a novel combined index, the triglyceride-glucose-visceral adiposity index (TyG-CVAI), with thyroid hormone sensitivity in T2DM. In this cross-sectional study, 7023 adult T2DM patients were recruited from two medical centers in China between June 2020 and August 2025. The composite index TyG-CVAI of obesity and insulin resistance is calculated based on triglyceride-glucose index (TyG) and Chinese visceral adiposity index (CVAI). Thyroid hormone sensitivity indicators were represented by thyroid feedback quantile Index (TFQI), thyroid-stimulating hormone index (TSHI), thyrotroph T4 resistance index (TT4RI) and FT3/FT4 ratio. Multivariable linear regression models adjusted for demographic, lifestyle, and clinical confounders were employed to explore the association of TyG-CVAI with thyroid hormone sensitivity indicators. In fully adjusted models, per one-standard deviation increase in TyG-CVAI was significantly associated with elevated TFQI (β = 0.01, 95% CI: 0.00-0.02, P = 0.019), TSHI (β = 0.07, 95% CI: 0.02–0.12, P = 0.005), and TT4RI (β = 3.06, 95% CI: 2.07–4.05, P < 0.001). Participants in the highest TyG-CVAI tertile showed greater increases in these indices compared to the lowest tertile (e.g., TT4RI: β = 6.30, 95% CI: 3.90–8.70, P < 0.001). These associations were robust in sensitivity analyses and more pronounced in women and those with shorter diabetes duration. Higher TyG-CVAI, reflecting combined insulin resistance and visceral adiposity, is associated with impaired thyroid hormone sensitivity in T2DM patients. No applicable.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: